Immunity, inflammation and disease · 2025
Immunoglobulin G4 Smoldering Multiple Myeloma With Immunoglobulin G4-Related Autoimmune Hepatitis: A Rare Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Long Jun, Shi Yuchen, Wang Xianyao, Zi Ying, Shi Rongjie
Аннотация
BACKGROUND: Multiple myeloma (MM) is a common malignant tumor of the hematological system caused by the malignant proliferation of plasma cells, characterized by the production of M proteins and CRAB symptoms. Among them, the Immunoglobulin G MM is the most common, while the IgG4-MM is extremely rare. Smoldering multiple myeloma refers to a state where there are no clinical symptoms. However, bone marrow plasma cell infiltration reaches 10%-59%, and previously, there were no reports of Immunoglobulin G4 smoldering multiple myeloma (IgG4 SMM) internationally.
CASE PRESENTATION: An over-50-year-old woman visited the hospital due to abnormal liver function. Laboratory tests showed a significant increase in serum IgG4 (24.95 g/L), and serum protein electrophoresis detected IgG-κ M protein (16.05 g/L). A liver biopsy showed IgG4 + plasma cell infiltration (11/HPF) and interface hepatitis. Bone marrow biopsy confirmed IgG4 monoclonal plasma cell proliferation. The diagnosis was IgG4-κ SMM combined with Immunoglobulin G4-related autoimmune hepatitis (IgG4-AIH) and primary biliary cholangitis (PBC). The patient had no typical CRAB symptoms, and no osteolytic destruction was found in imaging. So we formulated a chemotherapy regimen using Bortezomib and dexamethasone, combined with azathioprine for immunomodulation. Unfortunately, after one session of chemotherapy, the patient did not return to the hospital for further evaluation.
CONCLUSION: This article explores the clinical features and diagnostic challenges of IgG4 SMM coexisting with IgG4-AIH. IgG4 type SMM needs to be identified with IgG4-RD. Clinicians should pay attention to IgG subtype detection and clonal plasma cell analysis.
CASE PRESENTATION: An over-50-year-old woman visited the hospital due to abnormal liver function. Laboratory tests showed a significant increase in serum IgG4 (24.95 g/L), and serum protein electrophoresis detected IgG-κ M protein (16.05 g/L). A liver biopsy showed IgG4 + plasma cell infiltration (11/HPF) and interface hepatitis. Bone marrow biopsy confirmed IgG4 monoclonal plasma cell proliferation. The diagnosis was IgG4-κ SMM combined with Immunoglobulin G4-related autoimmune hepatitis (IgG4-AIH) and primary biliary cholangitis (PBC). The patient had no typical CRAB symptoms, and no osteolytic destruction was found in imaging. So we formulated a chemotherapy regimen using Bortezomib and dexamethasone, combined with azathioprine for immunomodulation. Unfortunately, after one session of chemotherapy, the patient did not return to the hospital for further evaluation.
CONCLUSION: This article explores the clinical features and diagnostic challenges of IgG4 SMM coexisting with IgG4-AIH. IgG4 type SMM needs to be identified with IgG4-RD. Clinicians should pay attention to IgG subtype detection and clonal plasma cell analysis.